Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Personalis, Inc. (PSNL)  
$1.54 0.03 (1.91%) as of 4:30 Mon 5/13


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 38,460,000
Market Cap: 59.23(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.9301 - $2.54
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    : 4.4
Insider 6 Months    : 4.4
Insider 3/6 Months : 9.1
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Personalis provides genetic tests for cancer. Co. also provides sequencing and data analysis services to support population sequencing initiatives. Co. operates and manages its business as one reportable operating segment, which is the sale of sequencing and data analysis services. Co.'s products include NeXT Platform, which is a platform that enable the analysis of both a tumor and its microenvironment from a single sample. Co. has created an ecosystem of products and capabilities built on the NeXT Platform: ImmunoID Next (tumor profiling from tissue), NeXT Liquid Biopsy (tumor profiling from plasma) and NeXT Personal (liquid biopsy providing for personalized tumor tracking for patients).

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 10,000 10,000 10,000 10,000
Total Buy Value $16,700 $16,700 $16,700 $16,700
Total People Bought 1 1 1 1
Total Buy Transactions 1 1 1 1
Total Shares Sold 4,523 22,702 41,220 125,853
Total Sell Value $6,197 $31,075 $69,252 $323,597
Total People Sold 1 3 3 4
Total Sell Transactions 1 9 17 49
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 196
  Page 4 of 8  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   West John Stephen President and CEO   •       •      –    2022-03-10 4/A A $1.84 $60,530 D/D 32,897 318,354     -
   West John Stephen President and CEO   •       •      –    2022-03-10 4 D $9.38 $308,574 D/D (32,897) 252,560     -
   Nieh Peter Affiliate of 10% Owner   –       –      –    2022-03-03 4 B $10.38 $49,305 D/D 4,750 4,750 2.44 -58%     
   Nieh Peter Affiliate of 10% Owner   –       –      –    2022-03-03 4 B $9.83 $2,565,738 I/I 261,011 2,084,240 0.01 -58%     
   Tachibana Aaron Chief Financial Officer   •       –      –    2022-03-02 4 S $10.18 $45,922 D/D (4,511) 251,441 61%     
   Chen Richard Chief Medical Officer   •       –      –    2022-03-02 4 S $10.18 $4,795 D/D (471) 157,334 61%     
   Nieh Peter Affiliate of 10% Owner   –       –      –    2022-03-02 4 B $9.96 $487,930 I/I 48,989 1,823,229 0.01 -61%     
   Bloom Olivia Kyusuk Director   –       •      –    2022-03-01 4 A $0.00 $0 D/D 10,245 10,245     -
   Moore Stephen Michael General CounselOfficer   •       –      –    2022-02-17 3 IO $0.00 $0 D/D 0 82,114 -66%     
   Tachibana Aaron Chief Financial Officer   •       –      –    2022-01-28 4 S $9.93 $7,001 D/D (705) 255,952 58%     
   Chen Richard Chief Medical Officer   •       –      –    2022-01-28 4 S $9.93 $7,001 D/D (705) 157,805 58%     
   West John Stephen President and CEO   •       •      –    2022-01-19 4 AS $11.01 $710,178 D/D (64,503) 285,457 -57%     
   West John Stephen President and CEO   •       •      –    2022-01-18 4 AS $11.73 $416,227 D/D (35,484) 349,960 -63%     
   Tachibana Aaron Chief Financial Officer   •       –      –    2021-12-17 4 S $12.80 $43,994 D/D (3,437) 256,657 62%     
   Chen Richard Chief Medical Officer   •       –      –    2021-12-17 4 S $12.80 $20,006 D/D (1,563) 158,510 62%     
   West John Stephen President and CEO   •       •      –    2021-12-17 4 AS $12.80 $34,970 D/D (2,732) 385,444 -62%     
   West John Stephen President and CEO   •       •      –    2021-12-16 4 AS $13.42 $1,305,337 D/D (97,268) 388,176 -55%     
   Chen Richard Chief Medical Officer   •       –      –    2021-12-14 4 A $0.00 $0 D/D 80,000 160,073     -
   Tachibana Aaron Chief Financial Officer   •       –      –    2021-12-14 4 A $0.00 $0 D/D 80,000 260,094     -
   Chen Richard Chief Medical Officer   •       –      –    2021-12-02 4 S $12.92 $5,413 D/D (419) 80,073 44%     
   Tachibana Aaron Chief Financial Officer   •       –      –    2021-12-02 4 S $12.92 $54,057 D/D (4,184) 180,094 44%     
   West John Stephen President and CEO   •       •      –    2021-11-30 4 AS $13.65 $1,365,000 D/D (100,000) 485,444 -45%     
   Tachibana Aaron Chief Financial Officer   •       –      –    2021-11-17 4 S $17.04 $21,351 D/D (1,253) 184,278 50%     
   West John Stephen President and CEO   •       •      –    2021-11-17 4 S $17.04 $40,010 D/D (2,348) 585,444 50%     
   Chen Richard Chief Medical Officer   •       –      –    2021-11-17 4 S $17.04 $21,351 D/D (1,253) 79,781 50%     
  196 Records found
  1  2  3  4  5  6  7  8   
  Page 4 of 8
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us